Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Massive Transfusion in Trauma Patient Registry
for
Trauma
Location: Dallas TX
Sponsor: Methodist Health System
Sex: All
Age: 18+
Code: NCT06136715
Recruiting
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
for
Regional Citrate Anticoagulation (RCA),
Location: Dallas TX, Memphis TN, Birmingham AL, Atlanta GA,
Sponsor: Vantive Health LLC
Sex: All
Age: 18+
Code: NCT05399537
Phase 3, Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
for
Diabetes Mellitus
Location: Dallas TX, Forney TX, Paradise Valley AZ,
Sponsor: Abbott Diabetes Care
Sex: All
Age: 18+
Code: NCT06668935
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
for
Atrophic Vaginitis, Vaginal Atrophy,
Location: Dallas TX, Birmingham AL, West Columbia SC,
Sponsor: Stratpharma AG
Sex: Female
Age: 18+
Code: NCT05953090
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Southlake TX, Austin TX, The Woodlands TX, Katy TX,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase 2, Recruiting
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
for
Breast Cancer, Breast Neoplasms, Breast Cancers
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT06517212
Phase 2, Recruiting
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
for
Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: Female
Age: 18+
Code: NCT04265872
Early Phase 1, Recruiting
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
for
Metastatic Triple-Negative Breast Carcinoma, Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: Female
Age: 18+
Code: NCT06008275
Early Phase 1, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Dallas TX, Houston TX, Aurora CO, Arlington Heights IL,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Dallas TX, St Louis MO, Indianapolis IN, Rochester MN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04926467
Phase 2, Recruiting
Analysis of Graft Function Following Autologous Islet Transplantation
for
Chronic Pancreatitis
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT03097185
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Location: Dallas TX, Plano TX, Waco TX, Oklahoma City OK,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 40+
Code: NCT05685303
Recruiting
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
for
HIV-1-infection
Location: Fort Worth TX, Dallas TX, Bellaire TX, Kansas City MO,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07708727
Phase 2, Phase 3, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Nashville TN, Denver CO, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Dallas TX, Baton Rouge LA, St Louis MO,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07170917
Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Dallas TX, Round Rock TX, Austin TX, Hot Springs AR,